Sei Investments CO Coherus Bio Sciences, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Sei Investments CO holds 342,427 shares of CHRS stock, worth $253,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares

342,427

Previous 355,392 3.65%

Holding current value

$253,395

Previous $614,000 42.02%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.99 - $1.8 $12,835 - $23,337	-12,965 Reduced 3.65%	342,427 $356,000
Q2 2024 Aug 13, 2024	SELL	$1.58 - $2.51 $2,505 - $3,980	-1,586 Reduced 0.44%	355,392 $614,000
Q1 2024 May 07, 2024	SELL	$2.02 - $3.14 $17,056 - $26,514	-8,444 Reduced 2.31%	356,978 $853,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $753,175 - $1.82 Million	-473,695 Reduced 56.45%	365,422 $1.22 Million
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $46,929 - $68,386	-12,548 Reduced 1.47%	839,117 $3.14 Million
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $436,403 - $955,711	115,146 Added 15.63%	851,665 $3.64 Million
Q1 2023 May 12, 2023	BUY	$5.89 - $10.52 $347,515 - $620,690	59,001 Added 8.71%	736,519 $5.04 Million
Q4 2022 Feb 10, 2023	BUY	$5.69 - $10.07 $82,835 - $146,599	14,558 Added 2.2%	677,518 $5.37 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $6,259 - $12,108	873 Added 0.13%	662,960 $6.37 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $210,918 - $476,187	35,993 Added 5.75%	662,087 $4.79 Million
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $962,729 - $1.45 Million	88,162 Added 16.39%	626,094 $8.08 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $3.07 Million - $3.68 Million	193,917 Added 56.37%	537,932 $8.59 Million
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $189,844 - $266,351	-14,972 Reduced 4.17%	344,015 $5.53 Million
Q2 2021 Aug 06, 2021	SELL	$12.95 - $15.41 $7,277 - $8,660	-562 Reduced 0.16%	358,987 $4.97 Million
Q1 2021 May 12, 2021	BUY	$14.42 - $21.39 $655,244 - $971,961	45,440 Added 14.47%	359,549 $5.25 Million
Q4 2020 Feb 08, 2021	BUY	$16.56 - $18.94 $1.79 Million - $2.05 Million	108,329 Added 52.64%	314,109 $5.46 Million
Q3 2020 Nov 06, 2020	BUY	$17.41 - $19.89 $1.68 Million - $1.92 Million	96,528 Added 88.35%	205,780 $3.77 Million
Q2 2020 Aug 17, 2020	BUY	$14.43 - $19.16 $1.24 Million - $1.64 Million	85,795 Added 365.75%	109,252 $1.95 Million
Q2 2020 Aug 11, 2020	BUY	$14.43 - $19.16 $65,151 - $86,507	4,515 Added 23.84%	23,457 $422,000
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $87,711 - $169,335	-7,516 Reduced 28.41%	18,942 $311,000
Q4 2019 Feb 06, 2020	SELL	$16.33 - $21.37 $116,204 - $152,068	-7,116 Reduced 21.19%	26,458 $477,000
Q3 2019 Nov 12, 2019	SELL	$16.3 - $23.37 $209,781 - $300,771	-12,870 Reduced 27.71%	33,574 $684,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $608,416 - $1.03 Million	46,444 New	46,444 $1.03 Million
Q1 2018 May 11, 2018	SELL	$9.1 - $13.7 $345 - $520	-38 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$11.1 - $14.5 $421 - $551	38	38 $1,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Coherus Bio Sciences, Inc. Transaction History